CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings
Beginning balance (in shares) at Mar. 31, 2023		6,231,082
Beginning balances at Mar. 31, 2023	$ 385,226,737		$ 288,071,839	$ 97,154,898
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Proceeds from exercise of stock options (in shares)		7,540
Proceeds from exercise of stock options	709,294		709,294
Stock-based compensation (reversal) related to restricted stock, net of cancellations (in shares)		1,875
Stock-based compensation (reversal) related to restricted stock, net of cancellations	1,099,351		1,099,351
Stock-based compensation related to stock options	313,347		313,347
Net income (loss)	9,538,748			9,538,748
Ending balance (in shares) at Jun. 30, 2023		6,240,497
Ending balances at Jun. 30, 2023	$ 396,887,477		290,193,831	106,693,646
Beginning balance (in shares) at Mar. 31, 2024	5,938,665	5,938,665
Beginning balances at Mar. 31, 2024	$ 424,427,216		286,432,952	137,994,264
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Proceeds from exercise of stock options (in shares)		7,011
Proceeds from exercise of stock options	686,382		686,382
Common stock repurchases (in shares)		(79,324)
Common stock repurchases	(11,254,770)			(11,254,770)
Stock-based compensation (reversal) related to restricted stock, net of cancellations (in shares)		(18,954)
Stock-based compensation (reversal) related to restricted stock, net of cancellations	(1,338,807)		(1,338,807)
Stock-based compensation related to stock options	143,720		143,720
Net income (loss)	$ 9,947,427			9,947,427
Ending balance (in shares) at Jun. 30, 2024	5,847,398	5,847,398
Ending balances at Jun. 30, 2024	$ 422,611,168		$ 285,924,247	$ 136,686,921